Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
03:14:12 EDT Sat 18 Apr 2026
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

Q:TDSGF - TELO GENOMICS CORP - https://www.3dsignatures.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
TDSGF - Qnot subscribed0.04    0.09  0.0315Apr 06Apr 1415 min RT 2¢

Recent Trades - All 0 today
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-04-14 07:01U:TDSGFNews ReleaseTelo Genomics Announces Study with University of Athens to Advance Next-Generation MRD Risk Stratification in Multiple Myeloma
2026-03-31 07:01U:TDSGFNews ReleaseTelo Genomics Announces Appointment of John Farlinger as CEO and Chairman
2026-01-29 08:01U:TDSGFNews ReleaseTelo Genomics Announces Appointment of John Price as Chief Financial Officer
2025-12-18 16:07U:TDSGFNews ReleaseTelo Genomics Launches Retrospective Blood-Based MRD Study with University of Athens as Part of 2026 Multi-Center Validation Program
2025-12-11 16:01U:TDSGFNews ReleaseTelo Genomics Presents Genomic Profiles of Peripheral Blood Minimal Residual Disease Cells at the 67th American Society of Hematology Meeting
2025-12-08 08:35U:TDSGFNews ReleaseTelo Genomics Corp to Present at the Small Cap Growth Virtual Investor Conference December 9th
2025-11-13 08:31U:TDSGFNews ReleaseTelo Genomics to Present Groundbreaking Individual-Cell Risk Assessment MRD Technology at the Myeloma Canada MRD Implementation Summit 2025
2025-10-09 08:32U:TDSGFNews ReleaseAmerican Society of Hematology Accepts Telo Genomics' Abstract for Presentation at its 2025 Meeting and Exposition
2025-09-30 16:31U:TDSGFNews ReleaseTelo Genomics Expands Operations with Relocation of Clinical Laboratories to New, Larger Toronto Facility and Provides Board Update
2025-09-19 08:31U:TDSGFNews ReleaseTelo Genomics Highlights New MRD Methodology at The 2025 International Myeloma Society Meeting
2025-09-08 16:21U:TDSGFNews ReleaseTelo Geonomics Announces Engagement of Investor Relations Service Provider
2025-08-05 16:11U:TDSGFNews ReleaseTelo Genomics to Present at the OTCQB Venture Virtual Investor Conference
2025-07-24 08:31U:TDSGFNews ReleaseInternational Myeloma Society Accepts Telo Genomics' MRD Abstract for Presentation at Its 2025 Meeting
2025-06-30 18:49U:TDSGFNews ReleaseTelo Genomics Corp. to File Statement of Defence and Counterclaim to Lawsuit Filed by Former President
2025-06-18 08:32U:TDSGFNews ReleaseTelo Genomics Initiate Clinical Trial for Minimal Residual Disease in Multiple Myeloma
2025-05-27 08:31U:TDSGFNews ReleaseTelo Genomics Receives New Client Tier under Intellectual Property Ontario (IPON)
2025-05-15 08:32U:TDSGFNews ReleaseEuropean Hematology Association Accepts Abstract from Telo Genomics for Presentation at The 2025 Congress